NYSE Euronext Paris Announces Listing of AbbVie Inc's Shares
NYSE Euronext Paris announced that the 1,576,667,492 existing shares representing the share capital of AbbVie Inc will be admitted to listing and trading on the professional segment of the regulated market of NYSE Euronext in Paris. The reference price of the shares will be the closing price of the Company's shares on December 19, 2012 on the NYSE, converted into EUR based on the EUR/USD exchange rate on December 19, 2012. The first trading of shares will take place as from December 20, 2012 up to (and including) December 31, 2012 on a single trading line 'ABBVIE - PROMESSES' under the code 'ABBVIE - PROMESSES', the ISIN code will be 'US00287Y1091' and the trading symbol 'ABBV'. As from January 2, 2013 (settlement-delivery date), the shares will be listed under the product name 'ABBVIE', the ISIN code and the trading symbol will remain the same.
Latest Developments for AbbVie Inc
- AbbVie Inc Presents Preliminary Results From Phase I Study Of Investigational Oncology Compound ABT-199/GDC-0199 In Patients With High-Risk Chronic Lymphocytic Leukemia (CLL)
- Bristol-Myers Squibb Co and AbbVie inc Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in Combination with Lenalidimide and Dexamethasone
- AbbVie Inc Announces First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination with HUMIRA (adalimumab) for Rheumatoid Arthritis
- AbbVie Inc Reaffirms FY 2013 EPS Guidance
Latest Key Developments in Pharmaceuticals
- Sichuan Kelun Pharmaceutical Co Ltd Amends Subsidiary Establishment Plan
- USFDA Issues Warning Letter To RPG Life Sciences Ltd-Business Standard
- Alk Abello A/S Announces Positive Outcome of Pivotal Phase III Trial with Allergy Immunotherapy Tablet against House Dust Mite Allergy
- EU Fines Ranbaxy Laboratories Ltd And Others For Blocking Cheaper Drugs-Business Standard
- Share this
- Link this
- Digg this


Follow Reuters